Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:613-614
Published online before print January 22, 2004, doi: 10.1161/01.STR.0000112970.63735.FC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/2/613    most recent
01.STR.0000112970.63735.FCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engelter, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engelter, S.

(Stroke. 2004;35:613.)
© 2004 American Heart Association, Inc.


Cochrane Corner

Antithrombotic Drugs for Carotid Artery Dissection

Philippe Lyrer, MD Stefan Engelter, MD

From the Neurological Clinic and Stroke Unit, University Hospital, Basel, Switzerland.

Correspondence to Philippe Lyrer, MD, Neurological Clinic and Stroke Unit, University Hospital Basel, Petersgraben 4, CH–4031 Basel, Switzerland. E-mail plyrer@uhbs.ch


Key Words: anticoagulants • antiplatelet agents • carotid artery, internal, dissection • review literature • stroke


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Extracranial internal carotid artery dissection can lead to occlusion of the artery and hence cause an ischemic stroke. It is the underlying stroke mechanism in approximately 2.5% of all strokes. It is the second leading cause of stroke in patients younger than 45 years of age. Anticoagulants or antiplatelets may prevent arterial thrombosis in extracranial internal carotid artery dissection, but these benefits may be offset by increased bleeding.

Objectives

To determine whether antithrombotic drugs (antiplatelet drugs, anticoagulation) are effective and safe in treatment of patients with extracranial internal carotid artery dissection (eICAD), and which is the better treatment.

Search Strategy

We searched the Cochrane Stroke Group Trials Register (last searched October 3, 2002). In addition we performed comprehensive searches of the Cochrane Central Register of Controlled Trials (Cochrane Library Issue 2, 2002), MEDLINE (January 1966 to May 2002), and EMBASE (January 1980 to June 2002), and checked all relevant papers for additional eligible studies.

Selection Criteria

Randomized controlled trials, controlled clinical trials assessing the efficacy of anticoagulants or antiplatelets for the treatment of extracranial internal carotid artery dissection, and nonrandomized trials, eg, case series (studies), that reported on any antithrombotic treatment with at least 4 patients, were eligible to be analyzed. Data from all eligible studies were extracted independently by 2 reviewers. Disagreements were resolved by discussion.

Data Collection and Analysis

Data on the primary outcome measures were extracted systematically. These were death (all causes) and death or disability. Secondary outcomes were first stroke occurrence, stroke recurrence, any stroke during reported follow-up, extracranial hemorrhage, and intracranial hemorrhage. The first . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
S. T. Engelter, M. P. Rutgers, F. Hatz, D. Georgiadis, F. Fluri, L. Sekoranja, G. Schwegler, F. Muller, B. Weder, H. Sarikaya, et al.
Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection
Stroke, December 1, 2009; 40(12): 3772 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H.-C. Diener and C. Weimar
Update of secondary stroke prevention
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1718 - 1724.
[Full Text] [PDF]


Home page
NeurologyHome page
D. Georgiadis, M. Arnold, H. C. von Buedingen, P. Valko, H. Sarikaya, V. Rousson, H. P. Mattle, M. G. Bousser, and R. W. Baumgartner
Aspirin vs anticoagulation in carotid artery dissection: A study of 298 patients
Neurology, May 26, 2009; 72(21): 1810 - 1815.
[Abstract] [Full Text] [PDF]


Home page
BMJ Case ReportsHome page
N. Rane and D. Mcauley
Vertebral artery dissection presenting as isolated vertigo
BMJ Case Reports, May 10, 2009; 2009(may10_1): bcr1120081238 - bcr1120081238.
[Abstract] [Full Text]


Home page
Emerg. Med. J.Home page
N J Rane and D Mcauley
Vertebral artery dissection presenting as isolated vertigo
Emerg. Med. J., October 1, 2007; 24(10): 732 - 732.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. G. Janzarik, P. A. Ringleb, M. Reinhard, and S. Rauer
Response to Letter by Menon and Norris
Stroke, May 1, 2007; 38(5): e17 - e17.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J.-M. de Bray and R. W. Baumgartner
History of Spontaneous Dissection of the Cervical Carotid Artery
Arch Neurol, July 1, 2005; 62(7): 1168 - 1170.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
Y. Yakushiji, M. Yasaka, T. Takada, and K. Minematsu
Serial Transoral Carotid Ultrasonographic Findings in Extracranial Internal Carotid Artery Dissection
J. Ultrasound Med., June 1, 2005; 24(6): 877 - 880.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
B Thanvi, S K Munshi, S L Dawson, and T G Robinson
Carotid and vertebral artery dissection syndromes
Postgrad. Med. J., June 1, 2005; 81(956): 383 - 388.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Abboud, E Houdart, E Meseguer, and P Amarenco
Stent assisted endovascular thrombolysis of internal carotid artery dissection
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 292 - 293.
[Full Text] [PDF]